Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
See allHide authors and affiliations
-
Communicated by Hector F. DeLuca, University of Wisconsin, Madison, WI (received for review December 15, 1997)

Abstract
Osteoclasts, the multinucleated cells that resorb bone, develop from hematopoietic cells of monocyte/macrophage lineage. Osteoclast-like cells (OCLs) are formed by coculturing spleen cells with osteoblasts or bone marrow stromal cells in the presence of bone-resorbing factors. The cell-to-cell interaction between osteoblasts/stromal cells and osteoclast progenitors is essential for OCL formation. Recently, we purified and molecularly cloned osteoclastogenesis-inhibitory factor (OCIF), which was identical to osteoprotegerin (OPG). OPG/OCIF is a secreted member of the tumor necrosis factor receptor family and inhibits osteoclastogenesis by interrupting the cell-to-cell interaction. Here we report the expression cloning of a ligand for OPG/OCIF from a complementary DNA library of mouse stromal cells. The protein was found to be a member of the membrane-associated tumor necrosis factor ligand family and induced OCL formation from osteoclast progenitors. A genetically engineered soluble form containing the extracellular domain of the protein induced OCL formation from spleen cells in the absence of osteoblasts/stromal cells. OPG/OCIF abolished the OCL formation induced by the protein. Expression of its gene in osteoblasts/stromal cells was up-regulated by bone-resorbing factors. We conclude that the membrane-bound protein is osteoclast differentiation factor (ODF), a long-sought ligand mediating an essential signal to osteoclast progenitors for their differentiation into osteoclasts. ODF was found to be identical to TRANCE/RANKL, which enhances T-cell growth and dendritic-cell function. ODF seems to be an important regulator in not only osteoclastogenesis but also immune system.
Footnotes
ABBREVIATIONS
- 1,
- 25(OH)2D3, 1,25-dihydroxyvitamin D3;
- Dex,
- dexamethasone;
- OCIF,
- osteoclastogenesis-inhibitory factor;
- OCL,
- osteoclast-like cell;
- ODF,
- osteoclast differentiation factor;
- OPG,
- osteoprotegerin;
- PGE2,
- prostaglandin E2;
- PTH,
- parathyroid hormone;
- sODF,
- soluble osteoclast differentiation factor;
- TRAP,
- tartrate-resistant acid phosphatase;
- TNF,
- tumor necrosis factor;
- M-CSF,
- macrophage colony-stimulating factor;
- MEM,
- α-minimal essential medium
- Received December 15, 1997.
- Accepted January 22, 1998.
- Copyright © 1998, The National Academy of Sciences